"Head and Neck Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
| Descriptor ID |
D006258
|
| MeSH Number(s) |
C04.588.443
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Head and Neck Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Head and Neck Neoplasms".
This graph shows the total number of publications written about "Head and Neck Neoplasms" by people in this website by year, and whether "Head and Neck Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 14 | 2 | 16 |
| 1995 | 26 | 5 | 31 |
| 1996 | 32 | 3 | 35 |
| 1997 | 22 | 5 | 27 |
| 1998 | 36 | 10 | 46 |
| 1999 | 36 | 3 | 39 |
| 2000 | 29 | 6 | 35 |
| 2001 | 35 | 3 | 38 |
| 2002 | 45 | 6 | 51 |
| 2003 | 39 | 6 | 45 |
| 2004 | 61 | 12 | 73 |
| 2005 | 53 | 8 | 61 |
| 2006 | 43 | 5 | 48 |
| 2007 | 70 | 4 | 74 |
| 2008 | 49 | 13 | 62 |
| 2009 | 53 | 8 | 61 |
| 2010 | 58 | 10 | 68 |
| 2011 | 72 | 9 | 81 |
| 2012 | 61 | 11 | 72 |
| 2013 | 62 | 4 | 66 |
| 2014 | 73 | 5 | 78 |
| 2015 | 61 | 2 | 63 |
| 2016 | 66 | 7 | 73 |
| 2017 | 70 | 10 | 80 |
| 2018 | 57 | 3 | 60 |
| 2019 | 60 | 6 | 66 |
| 2020 | 67 | 9 | 76 |
| 2021 | 65 | 5 | 70 |
| 2022 | 61 | 1 | 62 |
| 2023 | 49 | 0 | 49 |
| 2024 | 12 | 0 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Head and Neck Neoplasms" by people in Profiles.
-
TGF-?1 and TGF-?R1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation. Cancer Immunol Immunother. 2024 Mar 30; 73(5):85.
-
The Case for Allowing Proton Beam Therapy on Head and Neck Cooperative Group Studies. JAMA Oncol. 2024 Mar 01; 10(3):289-290.
-
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer. BMC Cancer. 2024 Feb 19; 24(1):233.
-
Cocaine use and head and neck cancer risk: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Med. 2024 Feb; 13(3):e7019.
-
Comprehensive insights on the underlying potential and advantage of proton therapy over intensity-modulated photon radiation therapy as highlighted in a wide real world data analysis. Radiother Oncol. 2024 Apr; 193:110122.
-
The fatigue-inducing effects of cancer and its therapy are characterized by decreased physical activity in the absence of any motivational deficit. Brain Behav Immun. 2024 03; 117:205-214.
-
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard-of-care? Cancer. 2024 03 15; 130(6):846-847.
-
Rehabilitation Interventions in Head and Neck Cancer: A Scoping Review. Am J Phys Med Rehabil. 2024 Mar 01; 103(3S Suppl 1):S62-S71.
-
Malignant carotid body tumors: What we know, what we do, and what we need to achieve. A systematic review of the literature. Head Neck. 2024 Mar; 46(3):672-687.
-
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner. Clin Cancer Res. 2024 01 05; 30(1):187-197.